Editorial: Immunosuppressive therapy in active chronic hepatitis.
出版信息
Br Med J. 1973 Nov 24;4(5890):441-2. doi: 10.1136/bmj.4.5890.441.
Abstract
摘要
相似文献
1
Editorial: Immunosuppressive therapy in active chronic hepatitis.社论：活动性慢性肝炎的免疫抑制治疗
Br Med J. 1973 Nov 24;4(5890):441-2. doi: 10.1136/bmj.4.5890.441.
2
[Immunosuppressive treatments of patients with autoimmune disorders].
Nord Med. 1967 Nov 9;78(45):1469-75.
3
Autoimmune hepatitis.自身免疫性肝炎
N Engl J Med. 1996 Apr 4;334(14):923-4. doi: 10.1056/NEJM199604043341415.
4
Autoimmunity and immunosuppressive therapy in active chronic hepatitis.自身免疫与活动性慢性肝炎的免疫抑制治疗
Med Chir Dig. 1973;2(6):319-21.
5
[Drug therapy of chronic active hepatitis].[慢性活动性肝炎的药物治疗]
Tidsskr Nor Laegeforen. 1980 May 20;100(14):974-6.
6
[Autoimmune diseases and immunosuppressive therapy. I. Immunosuppressive agents].
Acta Clin Belg. 1974;29(5):321-8. doi: 10.1080/17843286.1974.11716950.
7
[Treatment of autoimmune diseases].[自身免疫性疾病的治疗]
Schweiz Med Wochenschr. 1971 Oct 2;101(39):1393-9.
8
[Therapy of autoimmune hepatitis].[自身免疫性肝炎的治疗]
Dtsch Med Wochenschr. 1996 Dec 6;121(49):1539-42. doi: 10.1055/s-2007-1024049.
9
[Role of immunodepressants in the treatment of chronic active (lupoid) hepatitis].免疫抑制剂在慢性活动性（类狼疮样）肝炎治疗中的作用
Vestn Akad Med Nauk SSSR. 1975(6):64-70.
10
Immunosuppressive treatment of chronic liver disease.慢性肝病的免疫抑制治疗。
Ann N Y Acad Sci. 1993 Nov 30;696:319-27. doi: 10.1111/j.1749-6632.1993.tb17167.x.
本文引用的文献
1
The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine.用6-巯基嘌呤和硫唑嘌呤治疗活动性慢性肝炎。
Australas Ann Med. 1967 Nov;16(4):305-11. doi: 10.1111/imj.1967.16.4.305.
2
3
Cell-mediated immune responses in chronic liver diseases.慢性肝病中的细胞介导免疫反应。
Br Med J. 1972 Feb 26;1(5799):527-30. doi: 10.1136/bmj.1.5799.527.
4
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.皮质类固醇疗法治疗活动性慢性肝炎的对照前瞻性试验
Q J Med. 1971 Apr;40(158):159-85. doi: 10.1093/oxfordjournals.qjmed.a067264.
5
6
Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.肝脏疾病中的皮质类固醇：关于泼尼松向泼尼松龙的生物转化及血浆蛋白结合的研究
Gut. 1972 Sep;13(9):690-6. doi: 10.1136/gut.13.9.690.
7
Controlled trial of prednisone and azathioprine in active chronic hepatitis.泼尼松与硫唑嘌呤治疗活动性慢性肝炎的对照试验。
Lancet. 1973 Apr 7;1(7806):735-7. doi: 10.1016/s0140-6736(73)92125-9.
8
Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.活动性慢性肝炎和原发性胆汁性肝硬化患者对一种人肝脏特异性抗原的细胞介导免疫。
Lancet. 1972 Aug 12;2(7772):296-7. doi: 10.1016/s0140-6736(72)92904-2.
9
Prednisone side-effects and serum-protein levels. A collaborative study.泼尼松的副作用与血清蛋白水平。一项合作研究。
Lancet. 1971 Oct 9;2(7728):778-80. doi: 10.1016/s0140-6736(71)92738-3.
10
Cyclophosphamide and human organ transplantation.环磷酰胺与人体器官移植
Lancet. 1971 Jul 10;2(7715):70-4. doi: 10.1016/s0140-6736(71)92046-0.
Zotero 插件